Literature DB >> 16457868

Analysis of HIV-2 Vpx by modeling and insertional mutagenesis.

Lisa A Mahnke1, Michael Belshan, Lee Ratner.   

Abstract

Vpx facilitates HIV-2 nuclear localization by a poorly understood mechanism. We have compared Vpx to an NMR structure HIV-1 Vpr in a central helical domain and probed regions of Vpx by insertional mutagenesis. A predicted loop between helices two and three appears to be unique, overlapping with a known novel nuclear localization signal. Overall, Vpx was found to be surprisingly flexible, tolerating a series of large insertions. We found that insertion within the polyproline-containing C-terminus destabilizes nuclear localization, whereas mutating a second helix in the central domain disrupts viral packaging. Other insertional mutants in the predicted loop and in a linker region between the central domain and the C-terminus may be useful as sites of intramolecular tags as they could be packaged adequately and retained preintegration complex associated integration activity in a serum starvation assay. An unexpected result was found within a previously defined nuclear localization motif near aa 71. This mutant retained robust nuclear localization in a GFP fusion assay and was competent for preintegration complex associated nuclear import. In summary, we have modeled helical content in Vpx and assessed potential sites of intramolecular tags which may prove useful for protein-protein interactions studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457868     DOI: 10.1016/j.virol.2005.12.023

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  11 in total

1.  Hsp40 facilitates nuclear import of the human immunodeficiency virus type 2 Vpx-mediated preintegration complex.

Authors:  Xiaogang Cheng; Michael Belshan; Lee Ratner
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 2.  Lentivirus Vpr and Vpx accessory proteins usurp the cullin4-DDB1 (DCAF1) E3 ubiquitin ligase.

Authors:  Bizhan Romani; Eric A Cohen
Journal:  Curr Opin Virol       Date:  2012-10-10       Impact factor: 7.090

3.  HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection.

Authors:  Anna McCulley; Lee Ratner
Journal:  Virology       Date:  2012-03-03       Impact factor: 3.616

4.  Replication of biotinylated human immunodeficiency viruses.

Authors:  Michael Belshan; John M Matthews; Christian J Madson
Journal:  J Virol Methods       Date:  2010-11-16       Impact factor: 2.014

5.  Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells.

Authors:  Nicole Sunseri; Meagan O'Brien; Nina Bhardwaj; Nathaniel R Landau
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

6.  Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.

Authors:  Caroline Goujon; Vanessa Arfi; Thomas Pertel; Jeremy Luban; Julia Lienard; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

7.  Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx.

Authors:  Thomas Gramberg; Nicole Sunseri; Nathaniel R Landau
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

Review 8.  Host restriction factors in retroviral infection: promises in virus-host interaction.

Authors:  Yong-Hui Zheng; Kuan-Teh Jeang; Kenzo Tokunaga
Journal:  Retrovirology       Date:  2012-12-20       Impact factor: 4.602

9.  Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj.

Authors:  Silke Schüle; Björn-Philipp Kloke; Julia K Kaiser; Sabine Heidmeier; Sylvia Panitz; Nina Wolfrum; Klaus Cichutek; Matthias Schweizer
Journal:  PLoS One       Date:  2009-09-21       Impact factor: 3.240

10.  The efficiency of Vpx-mediated SAMHD1 antagonism does not correlate with the potency of viral control in HIV-2-infected individuals.

Authors:  Hangxing Yu; Shariq M Usmani; Alexandra Borch; Julia Krämer; Christina M Stürzel; Mohammad Khalid; Xuehua Li; Daniela Krnavek; Marchina E van der Ende; Albert D Osterhaus; Rob A Gruters; Frank Kirchhoff
Journal:  Retrovirology       Date:  2013-03-05       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.